Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
BACKGROUND: Trypanosomiasis, caused by protozoan parasites of the Trypanosoma genus, remains a significant health burden in several regions of the world. Cysteine proteases play a crucial role in the pathogenesis of Trypanosoma parasites and have emerged as potential therapeutic targets for the development of novel antiparasitic drugs.
INTRODUCTION: This review article aims to provide a comprehensive overview of the role of cysteine proteases in trypanosomiasis and their potential as therapeutic targets. We discuss the biological significance of cysteine proteases in Trypanosoma parasites and their involvement in essential processes, such as host immune evasion, cell invasion, and nutrient acquisition.
METHODS: A comprehensive literature search was conducted to identify relevant studies and research articles on the role of cysteine proteases and their inhibitors in trypanosomiasis. The selected studies were critically analyzed to extract key findings and provide a comprehensive overview of the topic.
RESULTS: Cysteine proteases, such as cruzipain, TbCatB and TbCatL, have been identified as promising therapeutic targets due to their essential roles in Trypanosoma pathogenesis. Several small molecule inhibitors and peptidomimetics have been developed to target these proteases and have shown promising activity in preclinical studies.
CONCLUSION: Targeting cysteine proteases and their inhibitors holds great potential for the development of novel antiparasitic drugs against trypanosomiasis. The identification of potent and selective cysteine protease inhibitors could significantly contribute to the combat against trypanosomiasis and improve the prospects for the treatment of this neglected tropical disease.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Current medicinal chemistry - (2023) vom: 19. Juni |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Saha, Aloke [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cathepsin B (TbCatB) |
|---|
| Anmerkungen: |
Date Revised 21.06.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.2174/0929867330666230619160509 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358422418 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358422418 | ||
| 003 | DE-627 | ||
| 005 | 20231226074716.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/0929867330666230619160509 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1194.xml |
| 035 | |a (DE-627)NLM358422418 | ||
| 035 | |a (NLM)37340748 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Saha, Aloke |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 21.06.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a BACKGROUND: Trypanosomiasis, caused by protozoan parasites of the Trypanosoma genus, remains a significant health burden in several regions of the world. Cysteine proteases play a crucial role in the pathogenesis of Trypanosoma parasites and have emerged as potential therapeutic targets for the development of novel antiparasitic drugs | ||
| 520 | |a INTRODUCTION: This review article aims to provide a comprehensive overview of the role of cysteine proteases in trypanosomiasis and their potential as therapeutic targets. We discuss the biological significance of cysteine proteases in Trypanosoma parasites and their involvement in essential processes, such as host immune evasion, cell invasion, and nutrient acquisition | ||
| 520 | |a METHODS: A comprehensive literature search was conducted to identify relevant studies and research articles on the role of cysteine proteases and their inhibitors in trypanosomiasis. The selected studies were critically analyzed to extract key findings and provide a comprehensive overview of the topic | ||
| 520 | |a RESULTS: Cysteine proteases, such as cruzipain, TbCatB and TbCatL, have been identified as promising therapeutic targets due to their essential roles in Trypanosoma pathogenesis. Several small molecule inhibitors and peptidomimetics have been developed to target these proteases and have shown promising activity in preclinical studies | ||
| 520 | |a CONCLUSION: Targeting cysteine proteases and their inhibitors holds great potential for the development of novel antiparasitic drugs against trypanosomiasis. The identification of potent and selective cysteine protease inhibitors could significantly contribute to the combat against trypanosomiasis and improve the prospects for the treatment of this neglected tropical disease | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cathepsin B (TbCatB) | |
| 650 | 4 | |a Cruzain | |
| 650 | 4 | |a Cysteine proteases inhibitors | |
| 650 | 4 | |a Rhodesain (TbCatL) | |
| 650 | 4 | |a Trypanosoma brucei | |
| 650 | 4 | |a Trypanosoma cruzi | |
| 650 | 4 | |a Trypanosomiasis | |
| 700 | 1 | |a Pushpa |e verfasserin |4 aut | |
| 700 | 1 | |a Moitra, Susmita |e verfasserin |4 aut | |
| 700 | 1 | |a Basak, Deblina |e verfasserin |4 aut | |
| 700 | 1 | |a Brahma, Sayandeep |e verfasserin |4 aut | |
| 700 | 1 | |a Mondal, Dipu |e verfasserin |4 aut | |
| 700 | 1 | |a Molla, Sabir Hossen |e verfasserin |4 aut | |
| 700 | 1 | |a Samadder, Asmita |e verfasserin |4 aut | |
| 700 | 1 | |a Nandi, Sisir |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current medicinal chemistry |d 1997 |g (2023) vom: 19. Juni |w (DE-627)NLM093833857 |x 1875-533X |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:19 |g month:06 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/0929867330666230619160509 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 19 |c 06 | ||